Target your Imaging Research with Bradykinin Receptor Modulators

MediLumine is honored to be named a finalist for the 2025 World Molecular Imaging Congress (WMIC) Commercial Innovation of the Year Award. The nomination recognizes

Vascular structure of the tumour. Three-dimensional rendering of the vascular structure of the LM8 osteosarcoma tumour as visualized in μCT after staining with Vascupaint. Background: